Cancer Immunotherapies

Solid Tumors and Hematologic Malignancies de

Éditeur :

Springer


Collection :

Cancer Treatment and Research

Paru le : 2022-05-12

eBook Téléchargement , DRM LCP 🛈 DRM Adobe 🛈
Lecture en ligne (streaming)
94,94

Téléchargement immédiat
Dès validation de votre commande
Image Louise Reader présentation

Louise Reader

Lisez ce titre sur l'application Louise Reader.

Description

This book presents the clinical scope of cancer immunotherapeutic agents for solid tumors and Hematologic malignancies, elaborates on the scientific details of their modes of action, and presents the impact of these agents on oncology, patients and the broader healthcare system. At present, cancer immunotherapies fall broadly into three categories: immune checkpoint inhibitors (ICIs), adoptive T cell therapies, and cancer vaccines which have distinct mechanisms of action. Immune checkpoint inhibitors rely upon disrupting tumor antigen recognition as self by the immune system through inhibition of checkpoint molecules. Adoptive T cell therapies involve the engineering of T cells ex vivo to target and destroy tumor cells.
The first part of this book will provide an overview of the discovery and mechanistic details of the technology. The second part will be devoted to elaborating on the clinical outcomes, successes and limitations for specific tumor subtypes, which includes bothsolid tumors and hematologic malignances for both pediatric and adult populations. As such, the book offers a valuable resource for oncologists, hematologists, and all those seeking an up-to-date overview of cancer immunotherapies.

Pages
315 pages
Collection
Cancer Treatment and Research
Parution
2022-05-12
Marque
Springer
EAN papier
9783030963750
EAN PDF
9783030963767

Informations sur l'ebook
Nombre pages copiables
3
Nombre pages imprimables
31
Taille du fichier
6072 Ko
Prix
94,94 €
EAN EPUB
9783030963767

Informations sur l'ebook
Nombre pages copiables
3
Nombre pages imprimables
31
Taille du fichier
16210 Ko
Prix
94,94 €